Growth Metrics

Humana (HUM) Receivables - Other (2016 - 2025)

Humana (HUM) has disclosed Receivables - Other for 14 consecutive years, with $159.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Receivables - Other changed N/A to $159.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $159.0 million, a N/A change, with the full-year FY2025 number at $159.0 million, changed N/A from a year prior.
  • Receivables - Other was $159.0 million for Q4 2025 at Humana, down from $181.0 million in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $188.0 million in Q4 2021 to a low of $159.0 million in Q4 2025.
  • A 3-year average of $176.0 million and a median of $181.0 million in 2022 define the central range for Receivables - Other.
  • Peak YoY movement for Receivables - Other: fell 3.09% in 2021, then dropped 3.72% in 2022.
  • Humana's Receivables - Other stood at $188.0 million in 2021, then dropped by 3.72% to $181.0 million in 2022, then fell by 12.15% to $159.0 million in 2025.
  • Per Business Quant, the three most recent readings for HUM's Receivables - Other are $159.0 million (Q4 2025), $181.0 million (Q4 2022), and $188.0 million (Q4 2021).